Next Article in Journal
Cut-off Values of the Respiratory Muscle Power and Peak Cough Flow in Post-Stroke Dysphagia
Next Article in Special Issue
On the Quest for In Vitro Platelet Production by Re-Tailoring the Concepts of Megakaryocyte Differentiation
Previous Article in Journal
Efficacy of the Arteriovenous Loop for Free Flap Reconstruction in Patients with Complex Limb Trauma: Case Series and Literature Review
 
 
Review
Peer-Review Record

The (Patho)Biology of SRC Kinase in Platelets and Megakaryocytes

Medicina 2020, 56(12), 633; https://doi.org/10.3390/medicina56120633
by Lore De Kock and Kathleen Freson *
Reviewer 2: Anonymous
Medicina 2020, 56(12), 633; https://doi.org/10.3390/medicina56120633
Submission received: 29 October 2020 / Revised: 17 November 2020 / Accepted: 21 November 2020 / Published: 24 November 2020
(This article belongs to the Special Issue Platelet Production and Function in Health and Disease)

Round 1

Reviewer 1 Report

De Kock and Freson present a concise and well-written short review on the SRC kinase biology in platelets and megakaryocytes.  It is balanced, well-referenced and up-to-date, and enjoyable to read.

Minor suggestions are found below:

  1. Consider adding information on non-redundancy of SFK isoforms in thrombo-inflammation (e.g. PMID 29974666).
  1. Does the fact that E527K patients present with a lack of α-granules support the role of SRC in granule formation in MKs? Please discuss briefly.
  1. Consider adding a section on the involvement of SRC kinase in the glycoprotein complex Ib-IX-V signaling (e.g. PMID 12393736 and others).
  2. Please harmonize abbreviations from 1st mention (e.g. MK, PTP, etc).
  3. Title of section 3, please correct “impaires” with “impairs”

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

This review article from L. De Kock and K. Freson focuses on the (patho)biology of Src kinases in platelets/megakaryocytes. This group has identified in 2019 a family of patients exhibiting a pathological gain of function Src mutation leading to thrombocytopenia and bleeding.

This is a very good review which summarizes the recent findings on the role of Src kinases in platelet and megakaryocytes and the impact of a gain of function mutation identified in patients. I have only a few remarks:

 Specific points:

  • Figure 2 and text: GPVI is associated with the FcR gamma-chain not with FcgRIIa, please clarify this point.
  • Some references showing the impact of Src inhibition on platelet in vivo (Blood 2009, 114, 1884-92), the potential role of CD148 on Src kinase activation (Blood 2012, 120, 1309-16) and the interaction of the SH3 domains of Src kinases with the proline-rich domain of GPVI (J Biol Chem 2002, 277, 21561-66) should be included.

Minor points:

  • Some typos to be corrected: “ 3. SRC kinase deficiency impairs platelet function”, etc…

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop